Skip to main content
SpringerLink
Log in

Progress toward identification of protease activity involved in proteolysis of apolipoprotein E in human brain

  • Neuroprotection
  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Apolipoprotein E (apoE) genotype is the single most important genetic risk factor for the most common (sporadic) form of Alzheimer’s disease (AD). Increasing evidence supports the hypothesis that the presence of the E4 isoform of this cholesterol-binding protein contributes directly to disease risk, age of onset, and severity of the neuropathology. For example, studies in transgenic mice demonstrate that apoE is necessary for the formation of plaques with neuritic pathology. The precise mechanism by which apoE contributes to the disease remains unknown. However, several lines of investigation from a number of laboratories now point to a role for proteolytic fragments of apoE in the formation of both plaques and tangles, the two pathological hallmarks of the disease. In particular, the C-terminal portion of apoE has been implicated in binding to amyloid and is localized to plaques. The N-terminal domain, on the other hand, is neurotoxic in culture and has been localized to, and implicated in the formation of, neurofibrillary tangles. These results suggest that inhibition of apoE proteolysis is a potential therapeutic strategy for AD. Using human brain homogenates, we have determined that proteolysis of apoE is greatest at acidic pH and can be inhibited by compounds targeting aspartic proteases. The feasibility of screening candidate inhibitors is supported by both ELISA and immunoblotting methods. Future studies will use a combination of in vitro and in vivo assays to test the efficacy of the most effective compounds for their ability to inhibit apoE proteolysis in human brain and apoE transgenic mouse brain tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aizawa Y., Fukatsu R., Takamaru Y., Tsuzuki K., Chiba H., et al. (1997) A mino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer’s disease-affected brains: a possible role for apolipoprotein E in Alzheimer’s disease. Brain Res. 768(1–2), 208–214.

    Article  PubMed  CAS  Google Scholar 

  • Amaratunga A., Abraham C. R., Edwards R. B., Sandell J. H., Schreiber B. M., et al. (1996) Apolipoprotein E is synthesized in the retina by Muller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells. J. Biol. Chem. 271(10), 5628–5632.

    Article  PubMed  CAS  Google Scholar 

  • Bales K. R., Verina T., Cummins D. J., Du Y., Dodel R. C., et al. (1999) Apolipoprotein E is essential for amyloid deposition in the APP (V717F) transgenic mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A. 96(26), 15233–15238.

    Article  PubMed  CAS  Google Scholar 

  • Bellosta S., Nathan B. P., Orth M., Dong L. M., Mahley R. W., et al. (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270(45), 27063–27071.

    Article  PubMed  CAS  Google Scholar 

  • Boyles J. K., Pitas R. E., Wilson E., Mahley R. W., and Taylor J. M. (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76(4), 1501–1513.

    PubMed  CAS  Google Scholar 

  • Bradley W. A., Gilliam E. B., Gotto A. M. J., and Gianturco S. H. (1982) Apolipoprotein E degradation in Human very low density lipoproteins by plasma protease(s): chemical and biological consequences. Biochem. Biophys. Res. Commun. 109, 1360–1367.

    Article  PubMed  CAS  Google Scholar 

  • Browning P. J., Roberts D. D., Zabrenetzky V., Bryant J., Kaplan M., et al. (1994) Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi’s sarcoma-like lesions in BALB/cnu/nu mice. J. Exp. Med. 180(5), 1949–1954.

    Article  PubMed  CAS  Google Scholar 

  • Buttini M., Akeefe H., Lin C., Mahley R. W., Pitas R. E., et al. (2000) Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 97(2), 207–210.

    Article  PubMed  CAS  Google Scholar 

  • Cambon K., Davies H. A., and Stewart M. G. (2000) Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice. Neuroscience 97(4), 685–692.

    Article  PubMed  CAS  Google Scholar 

  • Cho H. S., Hyman B. T., Greenberg S. M., and Rebeck G. W. (2001) Quantification of apoE domains in Alzheimer disease brain suggests a role for apoE in Aβ aggregation. J. Neuropathol. Exp. Neurol. 60, 342–349.

    PubMed  CAS  Google Scholar 

  • Clay M. A., Anantharamaiah G. M., Mistry M. J., Balasubramaniam A., and Harmony J. A. (1995) Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity. Biochemistry 34(35), 11142–11151.

    Article  PubMed  CAS  Google Scholar 

  • Colton C. A., Brown C. M., Cook D., Needham L. K., Xu Q., et al. (2002). APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress. Neurobiol. Aging 23(5), 777–785.

    Article  PubMed  CAS  Google Scholar 

  • Crutcher K. A., Clay M. A., Scott S. A., Tian X., Tolar M., et al. (1994) Neurite degeneration elicited by apolipoprotein E peptides. Exp. Neurol. 130(1), 120–126.

    Article  PubMed  CAS  Google Scholar 

  • Crutcher K. A., Tolar M., Harmony J. A., and Marques M. A. (1997) A new hypothesis for the role of apolipoprotein E in Alzheimer’s disease pathology, in Alzheimer’s Disease: Biology, Diagnosis and Therapeutics, Iqbal, K., Winblad B., Nishimura T., Taketa M., and Wisniewski H. M., eds., John Wiley, Chichester, U K, pp. 543–552.

    Google Scholar 

  • Cummings M. H., Watts G. F., Umpleby A. M., Hennessy T. R., Kelly J. M., et al. (1995) Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 44(9), 1059–1065.

    Article  PubMed  CAS  Google Scholar 

  • DeKroon R. M. and Armati P. J. (2001) The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes. Neurobiol. Dis. 8(1), 78–89.

    Article  PubMed  CAS  Google Scholar 

  • DeMattos R. B., Thorngate F. E. and Williams D. L. (1999). A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic. J. Neurosci. 19(7), 2464–2473.

    PubMed  CAS  Google Scholar 

  • Dyer C. A. and Curtiss L. K. (1988) Apoprotein E-rich high density lipoproteins inhibit ovarian androgen synthesis. J. Biol. Chem. 263(22), 10965–10973.

    PubMed  CAS  Google Scholar 

  • Fillit H. (2002) Economics, pharmacoeconomics and drug discovery for dementias. Drug Discov. Today 7(15), 785–787.

    Article  PubMed  Google Scholar 

  • Fillit H., Hill J. W., and Futterman R. (2002) Health care utilization and costs of Alzheimer’s disease: the role of co-morbid conditions, disease stage, and pharmacotherapy. Fam. Med. 34(7), 528–535.

    PubMed  Google Scholar 

  • Han S. H., Einstein G., Weisgraber K. H., Strittmatter W. J., Saunders A. M., et al. (1994a) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53(5), 535–544.

    PubMed  CAS  Google Scholar 

  • Han S. H., Hulette C., Saunders A. M., Einstein G., Pericak-Vance M., et al. (1994b) Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer’s disease and in age-matched controls. Exp. Neurol. 128(1), 13–26.

    Article  PubMed  CAS  Google Scholar 

  • Harris F. M., Brecht W. J., Xu Q., Tesseur I., Kekonius L., et al. (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer’s disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc. Natl. Acad. Sci. USA 100, 10966–10971.

    Article  PubMed  CAS  Google Scholar 

  • Hartman R. E., Wozniak D. F., Nardi A., Olney J. W., Sartorius L., et al. (2001) Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer’s-like neuropathology. Exp. Neurol. 170(2), 326–344.

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto Y., Jiang H., Niikura T., Ito Y., Hagiwara A., et al. (2000) Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases. J. Neurosci. 20(22), 8401–8409.

    PubMed  CAS  Google Scholar 

  • Holtzman D. M., Bales K. R., Tenkova T., Fagan A. M., Parsadanian M., et al. (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. U. S. A. 97(6), 2892–2897.

    Article  PubMed  CAS  Google Scholar 

  • Holtzman D. M., Bales K. R., Wu S., Bhat P., Parsadanian M., et al. (1999) Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer’s disease. J. Clin. Invest. 103(6), R15-R21.

    PubMed  CAS  Google Scholar 

  • Holtzman D. M., Pitas R. E., Kilbridge J., Nathan B., Mahley R. W., et al. (1995) Low density lipoprotein receptorrelated protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. U. S. A. 92(21), 9480–9484.

    Article  PubMed  CAS  Google Scholar 

  • Huang Y., Liu X. Q., Wyss-Coray T., Brecht W. J., Sanan D. A., et al. (2001) Apolipoprotein E fragments present in Alzheimer’s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl. Acad. Sci. U. S. A. 98(15), 8838–8843.

    Article  PubMed  CAS  Google Scholar 

  • Ignatius M. J., Gebicke-Harter P. J., Skene J. H., Schilling J. W., Weisgraber K. H., et al. (1986) Expression of apolipoprotein Eduring nerve degeneration and regeneration. Proc. Natl. Acad. Sci. U. S. A. 83(4), 1125–1129.

    Article  PubMed  CAS  Google Scholar 

  • Innerarity T. L., Friedlander E. J., Rall S. C., Weisgraber K. H., and Mahley R. W. (1983) The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J. Biol. Chem. 258(20), 12341–12347.

    PubMed  CAS  Google Scholar 

  • Innerarity T. L., Weisgraber K. H., Rall S. C., and Mahley R. W. (1987) Functional domains of apolipoprotein E and apolipoprotein B. Acta Med. Scand. Suppl. 715(12), 51–59.

    PubMed  CAS  Google Scholar 

  • Kobayashi M., Ishiguro K., Katoh-Fukui Y., Yokoayama M., and Fujita S. C. (2003) Phosphorylation state of tau in the hippocampus of apolipoprotein E4 and E3 knockin mice. Neuroreport 14, 699–702.

    Article  PubMed  CAS  Google Scholar 

  • Koppel R. (2002) Alzheimer’s disease: the cost to U.S. businesses in 2002, June, Alzheimer’s Association, Chicago, IL.

    Google Scholar 

  • Lendon C. L., Ashall F., and Goate A. M. (1997) Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 277(10), 825–831.

    Article  PubMed  CAS  Google Scholar 

  • Lins L., Thomas-Soumarmon A., Pillot T., Vandekerchkhove J., Rosseneu M., et al. (1999) Molecular determinants of the interaction between the C-terminal domain of Alzheimer’s beta-amyloid peptide and apolipoprotein E alpha-helices. J. Neurochem. 73(2), 758–769.

    Article  PubMed  CAS  Google Scholar 

  • Mahley R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240(4852), 622–630.

    Article  PubMed  CAS  Google Scholar 

  • Mahley R. W., Hui D. Y., Innerarity T. L., and Weisgraber K. H. (1981) Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors. J. Clin. Invest. 68(5), 1197–1206.

    PubMed  CAS  Google Scholar 

  • Mahley R. W., Innerarity T. L., Rall S. C., and Weisgraber K. H. (1985) Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia. Ann. N. Y. Acad. Sci. 454(8), 209–221.

    Article  PubMed  CAS  Google Scholar 

  • Mahley R. W., Innerarity T. L., Weisgraber K. H., Rall S. C., Hui D. Y., et al. (1986) Cellular and molecular biology of lipoprotein metabolism: characterization of lipoprotein receptor-ligand interactions. Cold Spring Harb. Symp. Quant. Biol. 51(Pt. 2[1]), 821–828.

    PubMed  CAS  Google Scholar 

  • Mahley R. W. and Ji Z. S. (1999) Remanant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40(1), 1–16.

    PubMed  CAS  Google Scholar 

  • Majack R. A., Castle C. K., Goodman L. V., Weisgraber K. H., Mahley R. W., et al. (1988) Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J. Cell. Biol. 107(3), 1207–1213.

    Article  PubMed  CAS  Google Scholar 

  • Marques M. A. and Crutcher K. A. (2003) Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer’s disease. J. Mol. Neurosci. 20(3), 117–127.

    Article  Google Scholar 

  • Marques M. A., Tolar A., and Crutcher K. A. (1997) Apolipoprotein E exhibits isoform-specific neurotoxicity. Alzheimer’s Res. 3, 1–6.

    CAS  Google Scholar 

  • Marques M. A., Tolar M., Harmony J. A. and Crutcher K. A. (1996) A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. Neuroreport 7(15–17), 2529–2532.

    Article  PubMed  CAS  Google Scholar 

  • Morrow J. A., Hatters D. M., Lu B., Hochtl P., Oberg K. A., et al. (2002) Apolipoprotein E4 forms a molten globule: A potential basis for Its association with disease. J. Biol. Chem. 277, 50380–50385.

    Article  PubMed  CAS  Google Scholar 

  • Nakai M., Kawamata T., Taniguchi T., Maeda K., and Tanaka C. (1996) Expression of apolipoprotein E mRNA in rat microglia. Neurosci. Lett. 211(1), 41–44.

    Article  PubMed  CAS  Google Scholar 

  • Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541(1), 163–166.

    Article  PubMed  CAS  Google Scholar 

  • Naslund J., Thyberg J., Tjernberg L. O., Wernstedt C., Karlstrom A. R., et al. (1995) Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer’s disease brain. Neuron 15(1), 219–228.

    Article  PubMed  CAS  Google Scholar 

  • Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W., et al. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264(5160), 850–852.

    Article  PubMed  CAS  Google Scholar 

  • Nathan B. P., Chang K. C., Bellosta S., Brisch E., Ge N., et al. (1995) The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270(34), 19791–19799.

    Article  PubMed  CAS  Google Scholar 

  • Paka L., Goldberg I. J., Obunike J. C., Choi S. Y., Saxena U., et al. (1999) Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth? J. Biol. Chem. 274(51), 36403–36408.

    Article  PubMed  CAS  Google Scholar 

  • Pillot T., Goethals M., Najib J., Labeur C., Lins L., et al. (1999) Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer’s disease. J. Neurochem. 72(1), 230–237.

    Article  PubMed  CAS  Google Scholar 

  • Poirier J. (1994) Apolipoprotein Ein animal models of CNS injury and in Alzheimer’s disease. Trends Neurosci. 17(12), 525–530.

    Article  PubMed  CAS  Google Scholar 

  • Price D. L. and Sisodia S. S. (1994) Cellular and molecular biology of Alzheimer’s disease and animal models. Annu. Rev. Med. 45(1), 435–446.

    Article  PubMed  CAS  Google Scholar 

  • Qiu Z., Crutcher K. A., Hyman B. T., and Rebeck G. W. (2003) ApoE isoforms affect neuronal NMDA calcium responses and toxicity via receptor-mediated processes. Neuroscience 122, 291–303.

    Article  PubMed  CAS  Google Scholar 

  • Saunders A. M., Schmader K., Breitner J. C., Benson M. D., Brown W. T., et al. (1993) Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer’s disease and in other amyloid-forming diseases. Lancet 342(8873), 710,711.

    Article  PubMed  CAS  Google Scholar 

  • Stannard A. K., Riddell D. R., Sacre S. M., Tagalakis A. D., Langer C., et al. (2001) Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J. Biol. Chem. 276(49), 46011–46016.

    Article  PubMed  CAS  Google Scholar 

  • Strittmatter W. J., Saunders A. M., Schmechel D., Pericak V. M., Enghild J., et al. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90(5), 1977–1981.

    Article  PubMed  CAS  Google Scholar 

  • Terry R. D. (1994). Neuropathological changes in Alzheimer disease. Prog. Brain Res. 101(2), 383–390.

    PubMed  CAS  Google Scholar 

  • Terry R. D. and Katzman R. (1983). Senile dementia of the Alzheimer type. Ann. Neurol. 14(5), 497–506.

    Article  PubMed  CAS  Google Scholar 

  • Tesseur I., Van Dorpe J., Spittaels K., Van den Haute C., Moechars D., et al. (2000) Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 156(3), 951–964.

    PubMed  CAS  Google Scholar 

  • Tolar M., Keller J. N., Chan S., Mattson M. P., Marques M. A., et al. (1999) Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J. Neurosci. 19(16), 7100–7110.

    PubMed  CAS  Google Scholar 

  • Tolar M., Marques M. A., Harmony J. A., and Crutcher K. A. (1997) Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J. Neurosci. 17(15), 5678–5686.

    PubMed  CAS  Google Scholar 

  • Vogel T., Guo N. H., Guy R., Drezlich N., Krutzsch H. C., et al. (1994). Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J. Cell. Biochem. 54(3), 299–308.

    Article  PubMed  CAS  Google Scholar 

  • Weisgraber K. H. (1994) Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45, 249–302.

    Article  PubMed  CAS  Google Scholar 

  • Weisgraber K. H., Innerarity T. L., Rall S. C., and Mahley R. W. (1985a) Apolipoprotein E: receptor binding properties. Adv. Exp. Med. Biol. 183(8), 159–171.

    PubMed  CAS  Google Scholar 

  • Weisgraber K. H., Innerarity T. L., Rall S. C., and Mahley R. W. (1985b) Receptor interactions controlling lipoprotein metabolism. Can. J. Biochem. Cell. Biol. 63(8), 898–905.

    Article  PubMed  CAS  Google Scholar 

  • Weisgraber K. H., Rall S. C., Mahley R. W., Milne R. W., Marcel Y. L., et al. (1986) Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J. Biol. Chem. 261(5), 2068–2076.

    PubMed  CAS  Google Scholar 

  • Wetterau J. R., Aggerbeck L. P., Rall S. C., and Weisgraber K. H. (1988) Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J. Biol. Chem. 263(13), 6240–6248.

    PubMed  CAS  Google Scholar 

  • Whitehouse P. J., Landreth G., and Younkin S. (1993) Molecular biology of Alzheimer’s disease. Mol. Genet. Med. 3, 95–137.

    PubMed  CAS  Google Scholar 

  • Wisniewski T., Golabek A., Matsubara E., Ghiso J., and Frangione B. (1993) Apolipoprotein E: binding to soluble Alzheimer’s beta-amyloid. Biochem. Biophys. Res. Commun. 192(2), 359–365.

    Article  PubMed  CAS  Google Scholar 

  • Wisniewski T., Lalowski M., Golabek A., Vogel T., and Frangione B. (1995) Is Alzheimer’s disease an apolipoprotein E amyloidosis? Lancet 345(8955), 956–958.

    Article  PubMed  CAS  Google Scholar 

  • Xu Q., Li Y., Cyras C., Sanan D. A., and Cordell B. (2000) Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein j-rich bute-poor spherical particle. J. Biol. Chem. 275(41), 31770–31777.

    Article  PubMed  CAS  Google Scholar 

  • Zeleny M., Swertfeger D. K., Weisgraber K. H., and Hui D. Y. (2002) Distinct apolipoprotein E isoform preference for inhibition of smooth muscle cell migration and proliferation. Biochemistry 41(39), 11820–11823.

    Article  PubMed  CAS  Google Scholar 

  • Zhang D., McQuade J.-A., Shockley K. P., Marques M. A., and Crutcher K. A. (2001) Proteolysis of apolipoprotein E and Alzheimer’s disease pathology. Alzheimers Rep. 4, 67–79.

    Google Scholar 

  • Zhu B., Kuhel D. G., Witte D. P., and Hui D. Y. (2000) Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am. J. Pathol. 157(6), 1839–1848.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. ApoLogic, Inc., 45219, Cincinnati, OH

    Marcos A. Marques, Phillip A. Owens & Keith A. Crutcher

  2. Department of Neurosurgery, University of Cincinnati College of Medicine, 45267, Cincinnati, OH

    Keith A. Crutcher

Authors
  1. Marcos A. Marques
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Phillip A. Owens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keith A. Crutcher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keith A. Crutcher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marques, M.A., Owens, P.A. & Crutcher, K.A. Progress toward identification of protease activity involved in proteolysis of apolipoprotein E in human brain. J Mol Neurosci 24, 73–80 (2004). https://doi.org/10.1385/JMN:24:1:073

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/JMN:24:1:073

Index Entries

Search

Navigation